Wednesday, October 23, 2024
spot_img

Alliance Witan PLC – Net Asset Value

ALLIANCE WITAN PLC
                 
At the close of business on Tuesday 22 October 2024:

The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was

–       excluding income, 1272.3p
                 
–       including income, 1273.3p
  
The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was

–       excluding income, 1288.8p

–       including income, 1289.8p

For further information, please contact: –

 
Juniper Partners Limited
Tel. +44 (0)131 378 0500

Notes

  1. Net Asset Values are calculated in accordance with published accounting policies and AIC guidelines.
  2. The fair value of the Company’s fixed loan notes is calculated by reference to a benchmark gilt.

Powered by SlickText.com

Hot this week

Alliance Witan PLC – Transaction In Own Shares

Alliance Witan PLCLEI: 213800SZZD4E2IOZ9W55  TRANSACTION IN OWN SHARES  Alliance Witan...

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Topics

Alliance Witan PLC – Transaction In Own Shares

Alliance Witan PLCLEI: 213800SZZD4E2IOZ9W55  TRANSACTION IN OWN SHARES  Alliance Witan...

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus...

SYNERGIE : Q3 2024 REVENUES

Q3 2024 REVENUES In challenging market conditions, SYNERGIE...

2024 third quarter turnover: 131.1 million euros

2024 third quarter turnover: 131.1 million euros ...
spot_img

Related Articles

Popular Categories

spot_img